Monoclonal Kappa Spike

Lab Reagents

Human IgG antibody Laboratories manufactures the monoclonal kappa spike reagents distributed by Genprice. The Monoclonal Kappa Spike reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Monoclonal. Other Monoclonal products are available in stock. Specificity: Monoclonal Category: Kappa Group: Spike

Spike information

Monoclonal Kappa light chain Antibody, Clone: HP6053
AMM02380G 0.1ml
EUR 580.8
Description: A Monoclonal antibody against Human Kappa light chain. The antibodies are raised in Mouse and are from clone HP6053. This antibody is applicable in WB and IHC-P, E

HRP*Monoclonal Mouse Anti- Human Ig KAPPA
C030243-10ml 10ml
EUR 1641.6

HRP*Monoclonal Mouse Anti- Human Ig KAPPA
C030243-1ml 1ml
EUR 373.2

FITC*Monoclonal Mouse Anti- Human Ig KAPPA
C030643-10ml 10ml
EUR 2148

FITC*Monoclonal Mouse Anti- Human Ig KAPPA
C030643-1ml 1ml
EUR 373.2

BIOTIN*Monoclonal Mouse Anti- Human Ig KAPPA
C030843-10ml 10ml
EUR 2148

BIOTIN*Monoclonal Mouse Anti- Human Ig KAPPA
C030843-1ml 1ml
EUR 373.2

Anti-Kappa light chain Rabbit Monoclonal Antibody
M05470-1 100ug/vial
EUR 476.4
Description: Rabbit Monoclonal Kappa light chain Antibody. Validated in IP, IF, IHC, ICC, WB and tested in Human.

KAPPA
KAPPAF2-100T 100 test
EUR 465.6

KAPPA
KAPPAPE2-100T 100 test
EUR 715.2

SARS-CoV Spike Antibody
3219-002mg 0.02 mg
EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3219-01mg 0.1 mg
EUR 523.7
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3221-002mg 0.02 mg
EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3221-01mg 0.1 mg
EUR 523.7
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS (IN1) Spike Peptide
3221P 0.05 mg
EUR 197.7
Description: (IN) SARS (IN1) Spike peptide

SARS-CoV Spike Antibody
3223-002mg 0.02 mg
EUR 206.18
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3223-01mg 0.1 mg
EUR 523.7
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.